CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins

Figure 6

PC3 cells, untreated (0) or treated with CXCL12 (200 ng/mL), were lysed and then cell lysates were analyzed by immunoblotting with anti-tyrosine-phosphorylated site-specific antibody against FAK. The total protein was detected by probing the blots with anti-FAK (bottom panel). The blot was performed three times and a representative one is shown.